StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.05−0.23 (-3.16%)

Close on Nov 17, 2026Market cap $194.59MP/E –Yield –

Precision BioSciences cash

Cash and short-term investments held at the end of each period.

Precision BioSciences's cash was $87.55M at Jun 30, 2026. For fiscal 2025 it was $115.59M, up 6.2% from the year before. The highest annual figure on record is $189.58M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$115.59M+6.2%
FY2024Dec 31, 2024$108.88M-6.7%
FY2023Dec 31, 2023$116.68M-38.5%
FY2022Dec 31, 2022$189.58M+32.0%
FY2021Dec 31, 2021$143.66M+60.0%
FY2020Dec 31, 2020$89.80M-50.4%
FY2019Dec 31, 2019$180.89M+75.3%
FY2018Dec 31, 2018$103.19M+64.3%
FY2017Dec 31, 2017$62.80M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$87.55M+40.7%
Q1 FY2026Mar 31, 2026$101.18M+31.0%
Q4 FY2025Dec 31, 2025$115.59M+6.2%
Q3 FY2025Sep 30, 2025$44.87M-55.7%
Q2 FY2025Jun 30, 2025$62.24M-49.6%
Q1 FY2025Mar 31, 2025$77.22M-43.9%
Q4 FY2024Dec 31, 2024$108.88M-6.7%
Q3 FY2024Sep 30, 2024$101.20M-17.2%
Q2 FY2024Jun 30, 2024$123.57M-10.3%
Q1 FY2024Mar 31, 2024$137.77M-12.9%
Q4 FY2023Dec 31, 2023$116.68M-38.5%
Q3 FY2023Sep 30, 2023$122.23M-42.4%
Q2 FY2023Jun 30, 2023$137.79M-25.2%
Q1 FY2023Mar 31, 2023$158.13M+36.1%
Q4 FY2022Dec 31, 2022$189.58M+32.0%
Q3 FY2022Sep 30, 2022$212.05M+32.1%
Q2 FY2022Jun 30, 2022$184.14M+5.9%
Q1 FY2022Mar 31, 2022$116.22M-39.9%
Q4 FY2021Dec 31, 2021$143.66M+60.0%
Q3 FY2021Sep 30, 2021$160.47M+54.1%
Q2 FY2021Jun 30, 2021$173.94M+37.1%
Q1 FY2021Mar 31, 2021$193.46M+25.5%
Q4 FY2020Dec 31, 2020$89.80M-50.4%
Q3 FY2020Sep 30, 2020$104.15M-49.5%
Q2 FY2020Jun 30, 2020$126.89M-43.9%
Q1 FY2020Mar 31, 2020$154.19M+32.4%
Q4 FY2019Dec 31, 2019$180.89M+75.3%
Q3 FY2019Sep 30, 2019$206.27M+61.7%
Q2 FY2019Jun 30, 2019$226.10M+80.4%
Q1 FY2019Mar 31, 2019$116.50M+144.0%
Q4 FY2018Dec 31, 2018$103.19M+64.3%
Q3 FY2018Sep 30, 2018$127.57M–
Q2 FY2018Jun 30, 2018$125.34M–
Q1 FY2018Mar 31, 2018$47.75M–
Q4 FY2017Dec 31, 2017$62.80M–

More Precision BioSciences figures

See a number that looks wrong?